Clinical Trials Logo

Clinical Trial Summary

The efficacy and safety of Cyclosporine A as rescue therapy for acute severe ulcerative colitis in long-term follow-up.


Clinical Trial Description

All UC patients treated with CyA in Tampere University Hospital between 2009 and 2018 were reviewed from patient records and analyzed. Amelioration of UC was defined as clinical response for rescue therapy with no need for colectomy or third-line rescue therapy at the same hospitalization as index flare. Relapse was defined as requiring further Cs treatment, re-hospitalization, biologicals, small molecules, or colectomy later in follow-up. Patients were followed-up from the date of index flare until colectomy, death, or the end of observation period. Adverse events related to treatment were assessed throughout the duration of treatment. Surgical complications were defined by using Clavien-Dindo classification (grade III-V classified as severe complications). The surgical complications in Cyclosporine-treated patients were compared to all patients operated for treatment refractor UC in Tampere University Hospital within the same follow-up period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05219656
Study type Observational [Patient Registry]
Source Tampere University Hospital
Contact
Status Completed
Phase
Start date January 1, 2009
Completion date January 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05867329 - A Trial for Acute Severe Ulcerative Colitis Phase 4
Recruiting NCT05466890 - Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC) Phase 2
Active, not recruiting NCT04925973 - Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management Phase 2
Completed NCT03578692 - Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC)
Recruiting NCT05998213 - Transfer of Feces in Ulcerative Colitis 2 Phase 2